Boston Scientific Corporation's new Guidant unit is facing about 300 class-action and individual lawsuits related to problems with Guidant heart devices that became public last year, Boston Scientific disclosed in a regulatory filing Wednesday. The lawsuit tally includes about 66 product-liability class-action suits and about 234 individual suits, Boston Scientific said in its quarterly filing with the Securities and Exchange Commission. The total number of lawsuits has grown by nearly 100 since Guidant last released a tally in late February. Guidant's cardiac rhythm management division is based in Arden Hills.
The
Star Tribune
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
Lax Quality Observed at Device Facility in China
The company failed to investigate a customer complaint about a malfunctioning device.
Three Breast Cancer Drugs Pose Risks of Lung Inflammation, FDA Says
Possible symptoms include shortness of breath while resting or during low physical activity, the agency said.
FDAnews Device Daily Bulletin
GUIDANT LAWSUITS AT 300, BOSTON SCI SAYS
May 12, 2006
